Rheumatology.

Identifieur interne : 002F60 ( Main/Exploration ); précédent : 002F59; suivant : 002F61

---

Rheumatology.

Auteurs : R. A. Asherson [Royaume-Uni] ; R. Cervera [Royaume-Uni] ; D. P. D'Cruz [Royaume-Uni] ; G. R. Hughes [Royaume-Uni]

Source :

• Postgraduate Medical Journal [ 0032-5473 ] ; 1991-02.

RBID : ISTEX:FA653495CCDEDF0E5768B379964CE3AD9A642EB5

English descriptors

• Teeft :
  • Abnormality, Acid sequences, Adverse effects, Aggressive therapy, Amino acids, Ankylosing spondylitis, Antibody, Antibody idiotypes, Antibody system, Anticardiolipin, Anticardiolipin antibodies, Anticentromere antibodies, Anticoagulant, Antifolate activity, Antigen antibody system, Antinuclear, Antinuclear antibodies, Antiphospholipid, Antiphospholipid antibodies, Antiphospholipid syndrome, Appetite suppressants, Arch intern, Arch ophthalmol, Arthritic symptoms, Arthritis, Arthritis rheum, Aseptic meningitis, Asherson, Autoantibody, Autoantibody systems, Autoimmune, Autoimmune phenomena, Azathioprine, Body weight, Bowel, Butterfly rash, Clin, Clin immunol immunopathol, Clin pathol, Clin rheumatol, Clinical associations, Clinical course, Clinical features, Clinical manifestations, Clinical subsets, Combination chemotherapy, Complete remission, Congenital, Congenital heart block, Connective tissue disease, Connective tissue disorder, Creatinine clearance, Curr opin rheumatol, Current science, Cutaneous, Cutaneous vasculitis, Cyclophosphamide, Cyclosporin, Deforming arthropathy, Dermatomyositis, Diagnostic significance, Diaphragm disease, Dietary supplementation, Diffuse cutaneous, Disease activity, Dos, Dose aspirin, Dose methotrexate, Early stages, Elderly patients, Engl, Environmental factors, Epithelial cells, Epitope, Erythematosus, Fetal loss, Folate deficiency, Folic acid, Further studies, Gamma interferon, Gastrointestinal intolerance, Genetic factors, Genetic susceptibility, Growth factor, Heart block, High dose, High frequency, High incidence, High levels, High rate, Higher incidence, Histocompatibility, Histocompatibility antigens, Human immunodeficiency virus, Human immunodeficiency virus infection, Hydroxychloroquine, Identical features, Idiopathic, Idiopathic variety, Idiotype, Immune, Immune complexes, Immune response, Immunodeficiency, Immunoglobulin, Immunol, Immunological, Immunological aspects, Infection, Infectious agents, Inflammatory, Inflammatory bowel disease, Inhibitor, Initial symptom, Interleukin, Intern, Interstitial lung disease, Intramuscular therapy, Intravenous, Intravenous gammaglobulin, Joint destruction, Juvenile dermatomyositis, Klebsiella pneumoniae, Laboratory features, Lancet, Large numbers, Limited cutaneous, Long term, Long term studies, Lower incidence, Lower limbs, Lung disease, Lupus, Lupus anticoagulant, Lupus erythematosus, Lupus patients, Lyme disease, Lymphocyte, Magnetic resonance imaging, Major histocompatibility, Major systems, Maternal antibodies, Methotrexate, Molecular mimicry, Monoclonal, Monoclonal antibodies, Monoclonal antibody, Multicentre study, Muscle fibres, Myositis, Necrotizing vasculitis, Neonatal lupus erythematosus, Neonatal lupus syndrome, Newer therapies, Nsaid, Obstet gynecol, Optic neuropathy, Other factors, Other hand, Other investigators, Pathogenesis, Peripheral blood, Physical therapy, Placebo, Plasma exchange, Polymyositis, Predictive value, Primary antiphospholipid syndrome, Proc natl acad, Procollagen mrna levels, Pseudomotor cerebri, Pulmonary hypertension, Randomized trials, Reactive, Reactive arthritis, Recent years, Receptor, Refractory, Renal, Renal disease, Renal function, Rheum, Rheumatic, Rheumatic diseases, Rheumatoid, Rheumatoid arthritis, Rheumatoid factor, Rheumatoid synovial fluid, Rheumatol, Rheumatological manifestations, Rheumatology, Salivary glands, Scleroderma, Scleroderma fibroblasts, Sclerosis, Secondary syndrome, Semin arthritis rheum, Serological, Serological features, Serological markers, Seronegative, Several trials, Side effect, Side effects, Skin involvement, Small bowel, Soluble receptors, Steroid, Steroid therapy, Strong association, Subset, Sulphasalazine, Suppl, Susceptibility, Syndrome, Synovial, Synovial fluid, Synovial fluids, Synovial tissue, Systemic, Systemic lupus erythematosus, Systemic sclerosis, Terminal complement, Therapy, Thrombocytopenia, Thyroid disease, Thyroid disorders, Tissue disease, Topical reviews, Toxicity, Variable region, Vascular disease, Vascular injury, Vasculitis, Viral, Wide variety.

Url:

• https://api.istex.fr/ark:/67375/NVC-WJC3S1ZX-P/fulltext.pdf

DOI: 10.1136/pgmj.67.784.114

Affiliations:

• Royaume-Uni
• Angleterre, Grand Londres
• Londres

---

Links toward previous steps (curation, corpus...)

• to stream Istex, to step Corpus: 001C22
• to stream Istex, to step Curation: 001C22
• to stream Istex, to step Checkpoint: 001D31
• to stream Main, to step Merge: 003027
• to stream Main, to step Curation: 002F60

---

Le document en format XML

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F60 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002F60 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:FA653495CCDEDF0E5768B379964CE3AD9A642EB5
   |texte=   Rheumatology.
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021